trending Market Intelligence /marketintelligence/en/news-insights/trending/h_sz6DXaFV7mNFYVomhS8g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Trillium Therapeutics adds board member

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Trillium Therapeutics adds board member

Trillium Therapeutics Inc. added Helen Tayton-Martin to its board of directors.

Tayton-Martin is the chief business officer of Adaptimmune Therapeutics plc.